P37 Trial design of the GRADUATE studies: Phase III, randomized, placebo-controlled studies evaluating gantenerumab in patients with early Alzheimer's disease. Issue 8 (August 2019) - Boada, M.; Ristic, S.; Pross, N.; Abi-Saab, D.; Bullain, S.; Andjelkovic, M.; Peters, O.; Delmar, P.; Hofmann, C.; Searle, A.; Baudler, M.; Fontoura, P.; et al.